Table A3.
Patient Group | Total No. of Patients |
PIK3CA Mutant |
|
---|---|---|---|
No. of Patients | % | ||
ER status | |||
Negative | 186 | 41 | 22.0 |
Positive | 169 | 39 | 23.1 |
Treatment arm | |||
Lapatinib | 124 | 29 | 23.4 |
Trastuzumab | 112 | 21 | 18.8 |
Lapatinib + trastuzumab | 119 | 30 | 25.2 |
Abbreviation: ER, estrogen receptor.